Biogenic Amines - Metabolism
Research News and Information

Monday, November 23, 2009

Combinational chelation therapy abrogates lead-induced neurodegeneration in rats.

8 Jul 2009 Lead, a ubiquitous and potent neurotoxicant causes oxidative stress which leads to numerous neurobehavioral and physiological alterations. The ability of lead to bind sulfhydryl groups or compete with calcium could be one of the reasons for its ... Read more...

Ligand-gated chloride channels are receptors for biogenic amines in C. elegans.

Jul 2009 Biogenic amines such as serotonin and dopamine are intercellular signaling molecules that function widely as neurotransmitters and neuromodulators. We have identified in the nematode Caenorhabditis elegans three ligand-gated chloride channels that ... Read more...

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines.

29 Jun 2009 Kynuramines represent their own class of biogenic amines. They are formed either by decarboxylation of kynurenines or pyrrole ring cleavage of indoleamines. N(2)-formylated compounds formed in this last reaction can be deformylated either ... Read more...

Latest indexed articles for 'Biogenic Amines - Metabolism'

These are the very latest articles for this heading:

• Combinational chelation therapy abrogates lead-induced neurodegeneration in rats. 8 Jul 2009
• Ligand-gated chloride channels are receptors for biogenic amines in C. elegans. Jul 2009
• Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. 29 Jun 2009
• Effects of clioquinol on memory impairment and the neurochemical modifications induced by scrapie infection in golden hamsters. 18 May 2009
• Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys. 13 May 2009
• First evidence of a membrane-bound, tyramine and beta-phenylethylamine producing, tyrosine decarboxylase in Enterococcus faecalis: a two-dimensional electrophoresis proteomic study. 29 Apr 2009
• Anxiety-related behavior and biogenic amine pathways in the rat following bilateral vestibular lesions. 29 Apr 2009
• Zonisamide increases dopamine turnover in the striatum of mice and common marmosets treated with MPTP. 27 Apr 2009
• Novel carbamate cholinesterase inhibitors that release biologically active amines following enzyme inhibition. 22 Apr 2009
• Trace amine-associated receptors as emerging therapeutic targets. 21 Apr 2009
• Drugs, biogenic amine targets and the developing brain. 15 Apr 2009
• Biogenic amine production by Oenococcus oeni isolates from malolactic fermentation of Tempranillo wine. 30 Mar 2009
• Octopamine and tyramine modulate pheromone-sensitive olfactory sensilla of the hawkmoth Manduca sexta in a time-dependent manner. 18 Mar 2009
• Morphological and physiological characteristics of the serotonin-immunoreactive neuron in the antennal lobe of the male oriental tobacco budworm, Helicoverpa assulta. 18 Mar 2009
• [Direct cell-cell communications and social behavior of cells in mammals, protists, and bacteria. Possible causes of multicellularity] 27 Feb 2009
• Thin-layer chromatography for the identification and semi-quantification of biogenic amines produced by bacteria. 19 Feb 2009
• Gonadotropic effects of dopamine in isolated workers of the primitively eusocial wasp, Polistes chinensis. 5 Feb 2009
• Neuronal activation in the CNS during different forms of acute renal failure in rats. 7 Jan 2009
• Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain. 6 Jan 2009
• The use of tripeptides for lead discovery of 5-HT4 receptor ligands. 30 Dec 2008

See a longer list of these articles.

Technical information about 'Biogenic Amines'

Definition: A group of naturally occurring amines derived by enzymatic decarboxylation of the natural amino acids. Many have powerful physiological effects (e.g., histamine, serotonin, epinephrine, tyramine). Those derived from aromatic amino acids, and also their synthetic analogs (e.g., amphetamine), are of use in pharmacology.

Registry Number: 0

Descriptor UI: D001679

Alternative terms: Biogenic Amines; Biogenic Amine; Amine, Biogenic; Amines, Biogenic;

Related Mesh Headings: Receptors, Biogenic Amine;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; biosynthesis; physiology;

Tree Number: D02.092.211;

History Note: 73(71)

Technical Notes: GEN or unspecified: prefer specific biogenic amine group term or specific biogenic amine indented under each